Northwest Biotherapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY1996 | — | $0 | $0 |
| FY1997 | — | $-4.2M | — |
| FY1998 | — | $-9.2M | — |
| FY1999 | — | $-14.8M | — |
| FY2000 | — | $-22.5M | — |
| FY2001 | — | $16.9M | — |
| FY2002 | — | $4.9M | — |
| FY2003 | — | $15.0K | — |
| FY2004 | — | $-5.2M | — |
| FY2005 | — | $-11.4M | — |
| FY2006 | — | $-5.9M | — |
| FY2007 | — | $5.8M | — |
| FY2008 | — | $-12.3M | — |
| FY2009 | — | $-20.7M | $65.0K |
| FY2010 | — | $-27.7M | $153.0K |
| FY2011 | — | $-52.2M | $24.0K |
| FY2012 | — | $-16.1M | $7.3M |
| FY2013 | — | $-9.8M | $18.5M |
| FY2014 | — | $-35.0M | $13.4M |
| FY2015 | $22.8M | $-4.7M | $21.8M |
| FY2016 | $31.7M | $-26.5M | $6.9M |
| FY2017 | $31.4M | $-67.3M | $117.0K |
| FY2018 | $16.8M | $-48.1M | $22.2M |
| FY2019 | $12.7M | $-45.1M | $372.0K |
| FY2020 | $14.8M | $-362.9M | $10.0M |
| FY2021 | $32.4M | $-124.0M | $15.2M |
| FY2022 | $21.5M | $-128.1M | $7.0M |
| FY2023 | $40.8M | $-65.8M | $2.1M |
| FY2024 | $62.7M | $-94.5M | $2.2M |
| FY2025 | $60.0M | $-60.3M | $3.0M |